Goldenberg Dermatology - Facebook profile Goldenberg Dermatology - twitter profile Goldenberg Dermatology - YouTube profile Goldenberg Dermatology - Google+ profile Goldenberg Dermatology - linkedin profile Goldenberg Dermatology - Feed

Opening Soon:
Goldenberg Dermatology, PC

14 East 75th St. NY NY 10021 | 212-405-8202 |

Dr. Goldenberg on

February 04th, 2014 | Category: Media,Skin Cancer


Screen Shot 2014-02-04 at 8.18.07 AM

We all know that melanoma is an epidemic. The most important factor in improving survival is early detection and surgical removal of the abnormal lesion. But there may be hope for those patients that waited too long to get checked – the FDA recently approved treatment with 2 new medications in combination. The combination of Mekinist with Tafinlar worked better than Tefinlar alone. This may offer hope to those patients with advanced disease.

Here is my quote:

Gary Goldenberg, MD, an assistant professor of dermatology and pathology at Mount Sinai Medical Center in New York City, agrees. “[The new FDA approval] is an important step in treatment of patients with advanced melanoma, but prevention and early detection, however, are still the best option for patients.”



Other Blog Entries:


    Schedule a Consultation

    *required fields

    I would like to subscribe to receive e-newsletters

    Media appearances

    Watch Video: Sun Damage Treatment In NYC - Dr. Goldenberg Discusses Sun Protection In New York

    Dr. Goldenberg discusses sun damage on ABC’s Good Morning America

    Read My Latest Blog Entries


    AcneCosmeticDr. GoldenbergEczema/DermatitisGift Certificates/Package DealsMediaPsoriasisRosaceaSkin CancerSTD's